Earlier quoted context omitted.
Yes, but the risk is death and there are alternatives that do not appear to have this risk. Why not pause until it is more well understood? In the US, the other vaccines are starting to become really readily available.
Because the rate of vaccination is still supply-limited at the moment. If everyone who would have received the J&J vaccine could get a safer alternative in the same time frame this might make sense. But they can't, so it doesn't. Do the math. It is all but certain that more people will die as a result of this pause than without it, even if you assume a worst-case clotting risk scenario under the current data.
Maybe other parts of the country are different.